School of Medicine
Showing 61-70 of 173 Results
-
Hirotaka Ieki
Postdoctoral Scholar, Cardiovascular Medicine
BioI am an MD, PhD physician-scientist aiming to advance precision medicine for cardiovascular disease through research in genomics and artificial intelligence.
MD, The University of Tokyo, Tokyo, 2013
Residency in Internal Medicine, National Center for Global Health and Medicine, Tokyo, 2013-2017
Residency in Cardiology, Sakakibara Heart Institute, Tokyo, 2015–2017
PhD, The University of Tokyo, Tokyo, 2021
Clinical Fellow in Cardiology, The University of Tokyo Hospital, Tokyo, 2021–2022
Postdoctoral Scholar, Stanford University, 2023–present
Research interest: Precision medicine in cardiovascular disease. Genomics, Artificial Intelligence -
Mathangi Janakiraman
Postdoctoral Scholar, Gastroenterology
Current Research and Scholarly InterestsI study how the gut ecosystem, gut function, and neuroimmune interactions change during aging and in diseases like Alzheimer’s. I investigate how dietary interventions, including fermented foods and ketones, modulate gut cells and physiology. My goal is to reveal mechanisms through which diet supports healthy aging and to advance dietary strategies for age‑associated diseases.
-
Vishnu Priya Kanakaveti
Postdoctoral Scholar, Oncology
Current Research and Scholarly InterestsI am interested in elucidating molecular mechanisms of MYC-driven drug resistance and immune evasion in cancer using computational and experimental models.
-
Andreas Kerschbaumer
Postdoctoral Scholar, Immunology and Rheumatology
BioDr. Andreas Kerschbaumer is a postdoctoral scholar in the Division of Immunology and Rheumatology at Stanford University, conducting research in the Robinson and Khatri Labs. His work integrates clinical rheumatology with computational and systems immunology, applying meta-analytic techniques on transcriptomic datasets to uncover mechanisms of autoimmunity and improve therapeutic strategies in rheumatology.
He trained in internal medicine and rheumatology at the Medical University of Vienna, Department of Medicine III, Division of Rheumatology, where he also completed his PhD under Professors Smolen and Aletaha on treatment outcomes in inflammatory arthritis, followed by his habilitation on strategies to optimize the interpretation of clinical trial data in rheumatoid and psoriatic arthritis.
Dr. Kerschbaumer has been actively engaged with the European Alliance of Associations for Rheumatology (EULAR), contributing as Fellow, Methodologist, and Co-Methodologist to multiple international taskforces, including the 2019, 2022, and 2025 rheumatoid arthritis recommendations and the 2019 and 2023 psoriatic arthritis recommendations. He is currently a member of the EULAR Quality of Care Committee and serves as Co-Abstract Chair of the ACR Rheumatoid Arthritis abstract committee.
